BGN keeps intensive contacts and on-going communication with industrial partners in Israel and worldwide. In the last few years alone, BGN signed agreements with over 150 companies including Israeli companies such as Teva, Ormat, Rosetta Genomics, Evogene, El-Op, ECI, Gilat, Raphael, Elbit, Mekorot, Elta, IAI, Solel and worldwide companies such as ExxonMobil, Invitrogen, Deutsche Telecom, GSK and others.

These on-going relationships often result in further research collaborations, technology transfer, joint ventures and discovery of new common interests not identified before. 

Selected Projects: 

Deutsche Telekom

Deutsche Telekom and Ben-Gurion University established a joint research institute, the "Deutsche Telekom Laboratories at Ben-Gurion University". This is the first R&D center outside Germany.

ExxonMobil

ExxonMobil partnered with Ben-Gurion University to commercialize an on-vehicle hydrogen production system. 

Ikaria

Ikaria to pay $285 mln for BGU invention: BL-1040.

GSK

GSK signed agreement to license BGU invention pneumococcal vaccine proteins. 

Zenith Solar

Zenith Solar - BGU Spin Off.

Invitrogen

Invitrogen Launches GIBBCO(r) AlgiMatrix(TM) 3D Culture System based on BGU invention